Silencing PD-1 and PD-L1 with nanoparticle-delivered small interfering RNA increases cytotoxicity of tumor-infiltrating lymphocytes

被引:65
作者
Wu, Yanheng [1 ]
Gu, Wenyi [1 ]
Li, Jiang [2 ]
Chen, Chen [3 ]
Xu, Zhi Ping [1 ]
机构
[1] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia
[2] Sun Yat Sen Univ, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[3] Univ Queensland, Queensland Brain Inst, Sch Biomed Sci, St Lucia, Qld 4072, Australia
关键词
breast cancer; cytokines; MCF-7; nanoparticles delivery; PD-1; PD-L1; siRNA; TILs; CALCIUM-PHOSPHATE NANOPARTICLES; CELL TRANSFER; CANCER; EXPRESSION; BREAST; SIRNA; IMMUNOTHERAPY; INHIBITION; BLOCKADE; GROWTH;
D O I
10.2217/nnm-2018-0237
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aim: To determine if silencing PD-1 on tumor-infiltrating lymphocytes (TILs) and its ligand-1 (PD-L1) on cancer cells will enhance the cytotoxicity of TILs. Materials & methods: Lipid-coated calcium phosphate nanoparticles were synthesized to deliver siRNAs against PD-1 and PD-L1 to TILs and breast cancer MCF-7 cells. The downregulation of PD-1/PD-L1 expressions was determined by real-time PCR and western blotting assays. The killing efficacy of TILs to MCF-7 cells was determined by cytotoxic T lymphocyte assay. Results: Lipid-coated calcium phosphate nanoparticles effectively delivered siRNAs and silenced PD-1 and PD-L1sh expression. The knockdown of either gene or both greatly improved the cytotoxicity of TILs. Conclusion: Silencing PD-1 and PD-L1 is an effective approach to increase TIL cytotoxicity to cancer cells.
引用
收藏
页码:955 / 968
页数:14
相关论文
共 44 条
[41]   Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape [J].
Woo, Seng-Ryong ;
Turnis, Meghan E. ;
Goldberg, Monica V. ;
Bankoti, Jaishree ;
Selby, Mark ;
Nirschl, Christopher J. ;
Bettini, Matthew L. ;
Gravano, David M. ;
Vogel, Peter ;
Liu, Chih Long ;
Tangsombatvisit, Stephanie ;
Grosso, Joseph F. ;
Netto, George ;
Smeltzer, Matthew P. ;
Chaux, Alcides ;
Utz, Paul J. ;
Workman, Creg J. ;
Pardoll, Drew M. ;
Korman, Alan J. ;
Drake, Charles G. ;
Vignali, Dario A. A. .
CANCER RESEARCH, 2012, 72 (04) :917-927
[42]   Increased PD-L1 expression in breast and colon cancer stem cells [J].
Wu, Yanheng ;
Chen, Mingshui ;
Wu, Peihong ;
Chen, Chen ;
Xu, Zhi Ping ;
Gu, Wenyi .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (05) :602-604
[43]   Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC [J].
Zhang, Yuan ;
Schwerbrock, Nicole M. J. ;
Rogers, Arlin B. ;
Kim, William Y. ;
Huang, Leaf .
MOLECULAR THERAPY, 2013, 21 (08) :1559-1569
[44]   Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy [J].
Zhang, Yuan ;
Kim, William Y. ;
Huang, Leaf .
BIOMATERIALS, 2013, 34 (13) :3447-3458